-+ 0.00%
-+ 0.00%
-+ 0.00%

The Zhitong Finance App learned that an analysis of insurance claim data found that if GLP-1 drugs for weight loss and diabetes were priced below $350 per month, payers — such as employers and plan sponsors — would achieve net savings due to reduced usage of related medical services.

Zhitongcaijing·11/15/2026 03:57:00
Listen to the news
The Zhitong Finance App learned that an analysis of insurance claim data found that if GLP-1 drugs for weight loss and diabetes were priced below $350 per month, payers — such as employers and plan sponsors — would achieve net savings due to reduced usage of related medical services.